Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
—1,100.611,106.151,114.281,098.89——
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
—612.30612.30616.40612.30——
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
—644.73645.31649.16642.15——
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
—827.09828.05833.90827.27——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
—214.82214.82216.61212.62——
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
—3,115.173,142.773,186.203,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
—910.43915.18923.94906.03——
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
—1,474.501,480.841,491.461,475.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
—2,405.872,415.572,420.792,398.99——
YPSN:SWX
Ypsomed Holding AG
CHF 285.80
-1.52%
(-4.40) 1D
Apr 22, 5:30:56 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for YPSN...
Open
CHF 287.20
High
CHF 288.40
Low
CHF 282.40
Mkt. cap
3.90B
Avg. vol.
21.50K
Volume
11.06K
Dividend
0.77%
Quarterly dividend
CHF 0.55
Ex dividend date
Jul 1, 2024
P/E ratio
20.11
52-wk high
CHF 441.50
52-wk low
CHF 260.50
EPS
CHF 14.21
Shares outstanding
13.65M
No. of employees
2K
News stories
From sources across the web
Profile
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology. Products include devices like insulin pens, auto-injectors, and infusion pumps, which help patients manage chronic conditions more easily and independently. In 2025, Ypsomed employs 2,800+ employees and has an annual turnover of 728.9 million Swiss Francs. The company is listed on SIX Swiss Exchange. Wikipedia
About Ypsomed Holding AG
CEOSimon Michel
Employees2K
Founded2003
Headquarters-
SectorMedical device
Websiteypsomed.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
212.43M
212.43M
181.34M
181.34M
Cost of goods sold
125.11M
125.11M
106.24M
106.24M
Cost of revenue
125.11M
125.11M
106.24M
106.24M
Research and development expenses
16.78M
16.78M
9.44M
9.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.14M
33.14M
28.14M
28.14M
Operating expense
51.15M
51.15M
-8.52M
-8.52M
Total operating expenses
176.26M
176.26M
97.73M
97.73M
Operating income
36.17M
36.17M
83.61M
83.61M
Other non operating income
-253.00K
-253.00K
-84.00K
-84.00K
EBT including unusual items
34.01M
34.01M
73.63M
73.63M
EBT excluding unusual items
34.01M
34.01M
81.40M
81.40M
Income tax expense
6.56M
6.56M
4.08M
4.08M
Effective tax rate
19.28%
19.28%
5.55%
5.55%
Other operating expenses
1.23M
1.23M
-46.09M
-46.09M
Net income
27.45M
27.45M
69.55M
69.55M
Net profit margin
12.92%
12.92%
38.35%
38.35%
Earnings per share
-
-
-
-
Interest and investment income
38.50K
38.50K
236.00K
236.00K
Interest expense
-1.66M
-1.66M
-1.11M
-1.11M
Net interest expenses
-1.62M
-1.62M
-870.00K
-870.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
44.08M
44.08M
102.22M
102.22M
Gain or loss from assets sale
1.06M
1.06M
-25.58M
-25.58M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer